Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koller

Showing results (921-930 of 5,222) with videos related to

Pageof 523
Sort By:
Current Opinion in Oncology|July 20, 2022
Venetoclax in combination with nucleoside analogs in acute myelogenous leukemiaBrian J Ball, Paul B Koller, Vinod Pullarkat
Journal of Applied Biomaterials & Biomechanics : JABB|August 27, 2010
Antimicrobial potential of bioactive bone cementsG Koller, J Roether, K Bruce, et al.
Vnitrni Lekarstvi|April 30, 2016
[Hormonal changes in inflammatory bowel disease]Jana Kollerová, Tomáš Koller, Tibor Hlavatý, et al.
Deutsche Medizinische Wochenschrift (1946)|November 14, 2003
[Neuroendocrine tumors of the gastrointestinal tract (NETGI) and second primary malignancies--which is dominant?]M Brune, B Gerdes, M Koller, et al.
Acta Chirurgiae Plasticae|September 27, 2006
Epidemiology and therapeutic aspects of burn injuries in Slovakia (1993-2003)J Babík, K Sopko, J Orság, et al.
Dementia and Geriatric Cognitive Disorders|September 27, 2003
Hospital admission circumstances and prevalence of frontotemporal lobar degeneration: a multicenter psychiatric state hospital study in GermanyB Ibach, H Koch, M Koller, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 23, 2013
Hepatocellular organic anion-transporting polypeptides (OATPs) and multidrug resistance-associated protein 2 (MRP2) are inhibited by silibininKatrin Wlcek, Fabienne Koller, Peter Ferenci, et al.
International Angiology : a Journal of the International Union of Angiology|May 29, 2012
Cancer as a risk factor for residual pulmonary embolismT Petrovic, T Koller, V Stvrtinova, et al.
Cornea|November 29, 2012
Riboflavin/ultraviolet a crosslinking of the paracentral corneaTobias Koller, Silvia Schumacher, Franz Fankhauser, et al.
Burns : Journal of the International Society for Burn Injuries|October 5, 2013
In vitro efficacy of various topical antimicrobial agents in different time periods from contamination to application against 6 multidrug-resistant bacterial strains isolated from burn patientsMarianna Hajská, Lívia Slobodníková, Helena Hupková, et al.
Pageof 523

Showing results (921-930 of 5,222) with videos related to

Sort By:
Pageof 523
Current Opinion in Oncology|July 20, 2022
Venetoclax in combination with nucleoside analogs in acute myelogenous leukemiaBrian J Ball, Paul B Koller, Vinod Pullarkat
Journal of Applied Biomaterials & Biomechanics : JABB|August 27, 2010
Antimicrobial potential of bioactive bone cementsG Koller, J Roether, K Bruce, et al.
Vnitrni Lekarstvi|April 30, 2016
[Hormonal changes in inflammatory bowel disease]Jana Kollerová, Tomáš Koller, Tibor Hlavatý, et al.
Deutsche Medizinische Wochenschrift (1946)|November 14, 2003
[Neuroendocrine tumors of the gastrointestinal tract (NETGI) and second primary malignancies--which is dominant?]M Brune, B Gerdes, M Koller, et al.
Acta Chirurgiae Plasticae|September 27, 2006
Epidemiology and therapeutic aspects of burn injuries in Slovakia (1993-2003)J Babík, K Sopko, J Orság, et al.
Dementia and Geriatric Cognitive Disorders|September 27, 2003
Hospital admission circumstances and prevalence of frontotemporal lobar degeneration: a multicenter psychiatric state hospital study in GermanyB Ibach, H Koch, M Koller, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 23, 2013
Hepatocellular organic anion-transporting polypeptides (OATPs) and multidrug resistance-associated protein 2 (MRP2) are inhibited by silibininKatrin Wlcek, Fabienne Koller, Peter Ferenci, et al.
International Angiology : a Journal of the International Union of Angiology|May 29, 2012
Cancer as a risk factor for residual pulmonary embolismT Petrovic, T Koller, V Stvrtinova, et al.
Cornea|November 29, 2012
Riboflavin/ultraviolet a crosslinking of the paracentral corneaTobias Koller, Silvia Schumacher, Franz Fankhauser, et al.
Burns : Journal of the International Society for Burn Injuries|October 5, 2013
In vitro efficacy of various topical antimicrobial agents in different time periods from contamination to application against 6 multidrug-resistant bacterial strains isolated from burn patientsMarianna Hajská, Lívia Slobodníková, Helena Hupková, et al.
Pageof 523